Cargando…

Bacterial and Viral Respiratory Tract Microbiota and Host Characteristics in Adults With Lower Respiratory Tract Infections: A Case-Control Study

BACKGROUND: Viruses and bacteria from the nasopharynx are capable of causing community-acquired pneumonia (CAP), which can be difficult to diagnose. We aimed to investigate whether shifts in the composition of these nasopharyngeal microbial communities can be used as diagnostic biomarkers for CAP in...

Descripción completa

Detalles Bibliográficos
Autores principales: Haak, Bastiaan W, Brands, Xanthe, Davids, Mark, Peters-Sengers, Hessel, Kullberg, Robert F J, van Houdt, Robin, Hugenholtz, Floor, Faber, Daniël R, Zaaijer, Hans L, Scicluna, Brendon P, van der Poll, Tom, Joost Wiersinga, W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906706/
https://www.ncbi.nlm.nih.gov/pubmed/34156449
http://dx.doi.org/10.1093/cid/ciab568
_version_ 1784665455360737280
author Haak, Bastiaan W
Brands, Xanthe
Davids, Mark
Peters-Sengers, Hessel
Kullberg, Robert F J
van Houdt, Robin
Hugenholtz, Floor
Faber, Daniël R
Zaaijer, Hans L
Scicluna, Brendon P
van der Poll, Tom
Joost Wiersinga, W
author_facet Haak, Bastiaan W
Brands, Xanthe
Davids, Mark
Peters-Sengers, Hessel
Kullberg, Robert F J
van Houdt, Robin
Hugenholtz, Floor
Faber, Daniël R
Zaaijer, Hans L
Scicluna, Brendon P
van der Poll, Tom
Joost Wiersinga, W
author_sort Haak, Bastiaan W
collection PubMed
description BACKGROUND: Viruses and bacteria from the nasopharynx are capable of causing community-acquired pneumonia (CAP), which can be difficult to diagnose. We aimed to investigate whether shifts in the composition of these nasopharyngeal microbial communities can be used as diagnostic biomarkers for CAP in adults. METHODS: We collected nasopharyngeal swabs from adult CAP patients and controls without infection in a prospective multicenter case-control study design. We generated bacterial and viral profiles using 16S ribosomal RNA gene sequencing and multiplex polymerase chain reaction (PCR), respectively. Bacterial, viral, and clinical data were subsequently used as inputs for extremely randomized trees classification models aiming to distinguish subjects with CAP from healthy controls. RESULTS: We enrolled 117 cases and 48 control subjects. Cases displayed significant beta diversity differences in nasopharyngeal microbiota (P = .016, R(2) = .01) compared to healthy controls. Our extremely randomized trees classification models accurately discriminated CAP caused by bacteria (area under the curve [AUC] .83), viruses (AUC .95) or mixed origin (AUC .81) from healthy control subjects. We validated this approach using a dataset of nasopharyngeal samples from 140 influenza patients and 38 controls, which yielded highly accurate (AUC .93) separation between cases and controls. CONCLUSIONS: Relative proportions of different bacteria and viruses in the nasopharynx can be leveraged to diagnose CAP and identify etiologic agent(s) in adult patients. Such data can inform the development of a microbiota-based diagnostic panel used to identify CAP patients and causative agents from nasopharyngeal samples, potentially improving diagnostic specificity, efficiency, and antimicrobial stewardship practices.
format Online
Article
Text
id pubmed-8906706
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-89067062022-03-10 Bacterial and Viral Respiratory Tract Microbiota and Host Characteristics in Adults With Lower Respiratory Tract Infections: A Case-Control Study Haak, Bastiaan W Brands, Xanthe Davids, Mark Peters-Sengers, Hessel Kullberg, Robert F J van Houdt, Robin Hugenholtz, Floor Faber, Daniël R Zaaijer, Hans L Scicluna, Brendon P van der Poll, Tom Joost Wiersinga, W Clin Infect Dis Major Articles and Commentaries BACKGROUND: Viruses and bacteria from the nasopharynx are capable of causing community-acquired pneumonia (CAP), which can be difficult to diagnose. We aimed to investigate whether shifts in the composition of these nasopharyngeal microbial communities can be used as diagnostic biomarkers for CAP in adults. METHODS: We collected nasopharyngeal swabs from adult CAP patients and controls without infection in a prospective multicenter case-control study design. We generated bacterial and viral profiles using 16S ribosomal RNA gene sequencing and multiplex polymerase chain reaction (PCR), respectively. Bacterial, viral, and clinical data were subsequently used as inputs for extremely randomized trees classification models aiming to distinguish subjects with CAP from healthy controls. RESULTS: We enrolled 117 cases and 48 control subjects. Cases displayed significant beta diversity differences in nasopharyngeal microbiota (P = .016, R(2) = .01) compared to healthy controls. Our extremely randomized trees classification models accurately discriminated CAP caused by bacteria (area under the curve [AUC] .83), viruses (AUC .95) or mixed origin (AUC .81) from healthy control subjects. We validated this approach using a dataset of nasopharyngeal samples from 140 influenza patients and 38 controls, which yielded highly accurate (AUC .93) separation between cases and controls. CONCLUSIONS: Relative proportions of different bacteria and viruses in the nasopharynx can be leveraged to diagnose CAP and identify etiologic agent(s) in adult patients. Such data can inform the development of a microbiota-based diagnostic panel used to identify CAP patients and causative agents from nasopharyngeal samples, potentially improving diagnostic specificity, efficiency, and antimicrobial stewardship practices. Oxford University Press 2021-06-22 /pmc/articles/PMC8906706/ /pubmed/34156449 http://dx.doi.org/10.1093/cid/ciab568 Text en © The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Major Articles and Commentaries
Haak, Bastiaan W
Brands, Xanthe
Davids, Mark
Peters-Sengers, Hessel
Kullberg, Robert F J
van Houdt, Robin
Hugenholtz, Floor
Faber, Daniël R
Zaaijer, Hans L
Scicluna, Brendon P
van der Poll, Tom
Joost Wiersinga, W
Bacterial and Viral Respiratory Tract Microbiota and Host Characteristics in Adults With Lower Respiratory Tract Infections: A Case-Control Study
title Bacterial and Viral Respiratory Tract Microbiota and Host Characteristics in Adults With Lower Respiratory Tract Infections: A Case-Control Study
title_full Bacterial and Viral Respiratory Tract Microbiota and Host Characteristics in Adults With Lower Respiratory Tract Infections: A Case-Control Study
title_fullStr Bacterial and Viral Respiratory Tract Microbiota and Host Characteristics in Adults With Lower Respiratory Tract Infections: A Case-Control Study
title_full_unstemmed Bacterial and Viral Respiratory Tract Microbiota and Host Characteristics in Adults With Lower Respiratory Tract Infections: A Case-Control Study
title_short Bacterial and Viral Respiratory Tract Microbiota and Host Characteristics in Adults With Lower Respiratory Tract Infections: A Case-Control Study
title_sort bacterial and viral respiratory tract microbiota and host characteristics in adults with lower respiratory tract infections: a case-control study
topic Major Articles and Commentaries
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906706/
https://www.ncbi.nlm.nih.gov/pubmed/34156449
http://dx.doi.org/10.1093/cid/ciab568
work_keys_str_mv AT haakbastiaanw bacterialandviralrespiratorytractmicrobiotaandhostcharacteristicsinadultswithlowerrespiratorytractinfectionsacasecontrolstudy
AT brandsxanthe bacterialandviralrespiratorytractmicrobiotaandhostcharacteristicsinadultswithlowerrespiratorytractinfectionsacasecontrolstudy
AT davidsmark bacterialandviralrespiratorytractmicrobiotaandhostcharacteristicsinadultswithlowerrespiratorytractinfectionsacasecontrolstudy
AT peterssengershessel bacterialandviralrespiratorytractmicrobiotaandhostcharacteristicsinadultswithlowerrespiratorytractinfectionsacasecontrolstudy
AT kullbergrobertfj bacterialandviralrespiratorytractmicrobiotaandhostcharacteristicsinadultswithlowerrespiratorytractinfectionsacasecontrolstudy
AT vanhoudtrobin bacterialandviralrespiratorytractmicrobiotaandhostcharacteristicsinadultswithlowerrespiratorytractinfectionsacasecontrolstudy
AT hugenholtzfloor bacterialandviralrespiratorytractmicrobiotaandhostcharacteristicsinadultswithlowerrespiratorytractinfectionsacasecontrolstudy
AT faberdanielr bacterialandviralrespiratorytractmicrobiotaandhostcharacteristicsinadultswithlowerrespiratorytractinfectionsacasecontrolstudy
AT zaaijerhansl bacterialandviralrespiratorytractmicrobiotaandhostcharacteristicsinadultswithlowerrespiratorytractinfectionsacasecontrolstudy
AT sciclunabrendonp bacterialandviralrespiratorytractmicrobiotaandhostcharacteristicsinadultswithlowerrespiratorytractinfectionsacasecontrolstudy
AT vanderpolltom bacterialandviralrespiratorytractmicrobiotaandhostcharacteristicsinadultswithlowerrespiratorytractinfectionsacasecontrolstudy
AT joostwiersingaw bacterialandviralrespiratorytractmicrobiotaandhostcharacteristicsinadultswithlowerrespiratorytractinfectionsacasecontrolstudy